We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
SRDX - SurModics - Biotech IPO
An SI Board Since March 1998
Posts SubjectMarks Bans Symbol
75 6 0 SRDX
Emcee:  Will Preska Type:  Unmoderated
SurModics is a supplier to some of the large biotech firms, such as Medtronic. SRDX IPO'd at $7.50, and the stock is moving up. They seem to have a lot of potential for growth. Comments?
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
75Another earnings report and another positive surprise. Stock up 26% today even Lance Bredvold1May 1
74Earnings report on Feb 1 was exquisite and as usual Gary made no effort to sugarLance Bredvold-February 15
73Medtronic (headquartered in Ireland where SRDX does most equip. mfg) was a majorLance Bredvold-January 6
72Earnings today and stock price jumped about 10% gradually during the day of the Lance Bredvold-11/8/2023
71Darn it; Earnings looked good as I expected today and the stock immediately jumLance Bredvold-8/2/2023
70Resilience of SRDX stock has surprised me for a few years. This morning the entLance Bredvold-7/6/2023
69And now I'm full of SRDX common having bought significant amounts right arouLance Bredvold-6/25/2023
68[graphic] Tue, June 20, 2023 at 4:30 AM MDT In this article: SRDX +10.12% Lance Bredvold-6/20/2023
67And another 22% moderating to about 15% on June 6 or so. Can be attributed to tLance Bredvold-6/18/2023
66Today SRDX rose 8% without any apparent justification except that investors seemLance Bredvold-6/8/2023
65"..."We are delighted with our progress towards achieving a PMA for thLance Bredvold-3/28/2023
64I've never understood why SRDX stock seems so bouyant. Good steady earningsLance Bredvold-2/27/2023
63I need to remind myself that SurVeil is not the only arrow in SRDX's quiver.Lance Bredvold-1/19/2023
62Well, that's a bummer. Premarket approval delayed by FDA request for more dLance Bredvold-1/19/2023
61And one more thing to keep in mind. I've always been impressed that neitherLance Bredvold14/28/2022
60Wow. Did I just hear Gary say they have 19 sales professionals at the end of 2nLance Bredvold-4/27/2022
59Finally selling below $40 after today's earnings report. I had expected theLance Bredvold-4/27/2022
58I guess what this means is that SRDX is now more of a "story stock". Lance Bredvold-11/15/2021
57I've liked the way Gary Maharaj speaks, clearly and without exaggeration. TLance Bredvold-11/14/2021
56New imaging agent for Alzheimers licensed to Amersham/GE. Last evening earninLance Bredvold-1/22/2004
55Article by Aron Anderson on intravitreal drug delivery. From Sept 1. Thanks toLance Bredvold-1/10/2004
54NitroMed nitric oxide PR for stents by: skiplarson98 (55/M/Montana) 01/08/04 12Lance Bredvold-1/8/2004
53Patent search: This effort becoming a compendium of helpful posts by foolishpremLance Bredvold-1/4/2004
52Lance, Just wanted to say thx for posting ... your objective of just showing keycooksbay95-12/17/2003
51Oct2002 review panel of the cypher sirolimus stent questions and discussion was Lance Bredvold-12/15/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):